Intended for healthcare professionals

CCBYNC Open access

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

BMJ 2018; 363 doi: (Published 14 November 2018) Cite this as: BMJ 2018;363:k4365

Linked news

SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation